NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study NurExone announces promising new data for its ExoPTEN nanodrug, highlighting progress towards commercial-grade manufacturing

NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer NurExone Announces the Transfer of Manufacturing of the Active Element in ExoPTEN Drug to a Commercial GMP Manufacturer

Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...